Dermapharm Holding SE buy DirectorDealer
Start price
02.01.25
/
50%
€41.05
Target price
02.01.26
-
Performance (%)
-6.21%
End price
03.01.26
€38.50
Summary
This prediction ended on 03.01.26 with a price of €38.50. With a performance of -6.21%, the BUY prediction for Dermapharm Holding SE by DirectorDealer closed slightly in the red. DirectorDealer has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. DirectorDealer has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dermapharm Holding SE | -0.391% | -0.391% | -4.375% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
Comments by DirectorDealer for this prediction
In the thread Dermapharm Holding SE diskutieren
Director's Dealing / Insider Kauf von Beier, Wilhelm (Aufsichtsrat)
- Handelstag: 30.12.2024
- Volumen: 3894961 €
- Meldende_r: Beier, Wilhelm
In the thread Trading Dermapharm Holding SE
Die von DirectorDealer gewählte maximale Laufzeit wurde überschritten